Since all the patients analyzed in our study underwent radio- and chemotherapy treatments, the positive prognostic value of PDE5 expression may rely on the effect of this enzyme on GBM cells sensitivity to DNA-damaging agents. Here, PDE5A is linked to glioblastoma.